SlideShare a Scribd company logo
1 of 77
Design of Experiments (DOE):  A “New” Approach to Reaction Optimization Dr. Steven Weissman Merck & Co.  Feb 4, 2008/UPR
Outline ,[object Object],[object Object],[object Object],[object Object]
Big Changes for Big Pharma ,[object Object],[object Object],[object Object],[object Object],[object Object]
Big Changes for Big Pharma ,[object Object],[object Object],[object Object],[object Object],[object Object]
Big Changes for Big Pharma ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Big Changes for Big Pharma ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Big Changes for Big Pharma ,[object Object],[object Object],[object Object],[object Object]
New Approaches Needed ,[object Object],[object Object],[object Object]
New Approaches Needed ,[object Object],[object Object],[object Object]
Automated Synthesis Cycle Design Experiment Analysis Informatics
Automated Synthesis Cycle Design Experiment Analysis Informatics Design of Experiments
Current Approach to Optimization ,[object Object],[object Object],[object Object],[object Object],[object Object]
Current Approach to Optimization ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Example of OFAT (11/07)
21 Reactions
DOE vs OFAT ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Notable Quote ,[object Object],[object Object]
What is DOE ? ,[object Object],[object Object],[object Object],[object Object],[object Object]
DoE Introduction Core Knowledge (Engineering, Chemistry, Biology,…) Statistical Knowledge Develop Solutions DOE is NOT a replacement for process knowledge
Questions to be Answered by DoE ,[object Object],[object Object],[object Object],[object Object],[object Object]
DOE: Considerations ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
DOE: Experimental Objectives ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
DOE: Misconceptions   ,[object Object],[object Object],[object Object]
DOE: Misconceptions   ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
High Throughput Screening = 96 x Discreet variables- ‘The what” What is the best ligand/catalyst combination ? What is the best solvent ?
High Throughput Screening = 96 x Can we do OPTIMIZATION this way too ??
High Throughput Optimization ?? = 96 x If so,………………….. Which reactions do we run ? How do assess the data ?
High Throughput Optimization ?? = 96 x Statistical Design of Experiments (DOE)
HTS Reaction Vials
DOE: Workflow ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
DOE Design (N=27) 64 0.25 1.85 0.875 4 100 20 58 0.25 1.85 0.875 2 100 19 66 0.25 1.85 0.875 3 115 18 64 0.25 1.85 0.875 3 85 17 76 0.4 2.5 1.5 4 115 16 80 0.1 2.5 1.5 4 85 15 65 0.1 2.5 1.5 2 115 14 79 0.4 2.5 1.5 2 85 13 76 0.1 2.5 0.25 4 115 12 88 0.4 2.5 0.25 4 85 11 63 0.4 2.5 0.25 2 115 10 48 0.1 2.5 0.25 2 85 9 54 0.1 1.2 1.5 4 115 8 39 0.4 1.2 1.5 4 85 7 55 0.4 1.2 1.5 2 115 6 45 0.1 1.2 1.5 2 85 5 55 0.4 1.2 0.25 4 115 4 43 0.1 1.2 0.25 4 85 3 49 0.1 1.2 0.25 2 115 2 45 0.4 1.2 0.25 2 85 1 Yield E:Conc D:Boron/Br C:Cu B:P/Pd A:temp Rxn # Response 1 Factor 5 Factor 4 Factor 3 Factor 2 Factor 1
DOE Creates a Design Space Design-Expert® Software Yield X1 = A: temp X2 = B: P/Pd X3 = C: Cu load Actual Factors D: Boron/Br = 2.50 E: Conc = 0.40 Cube Yield A: temp B: P/Pd C: Cu load A-: 85.00 A+: 115.00 B-: 2.00 B+: 4.00 C-: 0.25 C+: 1.50 63.7936 74.1825 86.3492 83.738 59.9047 70.2936 82.4603 79.8492
DOE Expts: How Many ? screening  optimaztion 29 9 11 9 5 27 10 7 10 4 17 5 7 5 3 35 16 3 16 5  19 8 3 8 4 11 4 3 4 3 factors Total rxns Lo Med  HI rxns factors
DOE Case Studies
MK-0518 First-in-Class Oral HIV-1 Integrase Inhibitor Approved by FDA October-12-2007
MK-0518
MK-0518 Challenge: to reduce manufacture cost by 20%
MK-518: Problem step Peter Maligres Existing Conditions :  4 eq Mg(OMe) 2 / 4 eq MeI  @  0.5 M (68% isolated yield) 18 solvents,  8 bases screened 78   22
MK-518: DOE Optimization Peter Maligres DOE Optimzation Design Factors :  Mg(OMe) 2  equiv:  1.0 and 3.0 MeI equiv:  2.5 and 5.0 Conc:  0.25 and 1.0 M Temperature:  30 and 65  o C 19 reactions Responses (4 and 20 h): Assay yield Selectivity
MK-518 Optimization Peter Maligres DOE Optimal Settings Base equiv:  1.0   and  3.0  MeI equiv:  2.5 and  5.0 Temperature:  30 and  65  o C Conc:  0.25 and  1.0 M Time:  4 and  20 h 99   1
MK 518: Surface Model
Effect of Temp & Conc
Effect of Base and Conc
MK518-In Situ Demethylation 99/1 80/20 N vs O 99% 95% Conv 20 h 4 h
MK-518 Concerns Peter Maligres ,[object Object],[object Object],[object Object],[object Object],99   1
MK-518 Optimization Peter Maligres Yield =90% Selectivity = >99.9 % Safer, more economical reagents Incorporated best practices from DOE: HI Temp/HI Concentration/Longer reaction times
MK-518 Summary 78 22 > 99 < 1 DOE Goal of 20% reduction in drug inventory cost was achieved Higher Yield cascades back to allow fewer RM/solvents to be used Submitted for 2008 Presidential Green Chemistry Award
Case Study 2- Suzuki ,[object Object],[object Object],[object Object]
Case Study 2- Suzuki DOE Factors : Ligand/Pd ratio:  1.0 and 3.0 Catalyst load:  0.1 and   0.5 mole% Molarity boronic acid:  0.5 and 1.5 Temperature:  60 and 80  o C 27 Reactions in 96-well plate format,  2 days to plan/setup/execute/assay 0.65 g material (24 mg/rxn) !!
Case Study 2- Suzuki DOE Optimal Settings : Ligand/Pd ratio:  1.0 and  3.0 Catalyst load:  0.1 and   0.5  mole% Molarity boronic acid :  0.5 and  1.5 Temperature: 60  and 80  o C  ( 65  o C )
Effect of Temp and Pd Loading Lig/ catalyst ratio fixed at 3:1; Triol M fixed at 1.5 M Overall LCAP
Optimized  Conditions Optimized Experiment: -increased LCAP by 1% -decreased DesBr impurity (50%) -decreased Pd by 75% -decreased Lig by 70% Spencer Dreher
Case Study #3 Dave Pollard Goal: to reduce cost by increasing productivity 100 g/L
Screening Design Dave Pollard Factors Octanol:  40 and 60 % NADP equiv:  0.1 and 0.5 % Concentration: 50 and 150 g/L Temp: 25 and 35  o C Enzyme load:  0.3 to 1.0  g/L 19 experiments
DOE  Factors Plot
Interaction: Conc and NAD
Screening Result Dave Pollard Factor Preferred Setting Octanol:  40 and 60 % No impact NADP equiv:  0.1 and 0.5 % No impact-  increase more ?   Concentration: 50 and 150 g/L 50 g/L-  undesirable setting Temp: 25 and 35  o C minimal effect- set at 30  o C Enzyme load:  0.3 to 1.0  g/L 1.0 g/L- increase more
Optimization Design Dave Pollard Factor NADP equiv:  0.5 and 1.5 %   Concentration: 100 and 200 g/L Enzyme load:  0.5 to 3.0  g/L 19 experiments
Optimization Design Factor  Preferred setting NADP equiv:  0.5 and 1.5 %   No effect   Concentration: 100 and 200 g/L 200 Enzyme load:  0.5 to 3.0  g/L 3.0
Optimization Design Factor  Preferred setting NADP equiv:  0.5 and 1.5 %   No effect   Concentration: 100 and 200 g/L 200 Enzyme load:  0.5 to 3.0  g/L 3.0 Confirming experiment at 200 g/L NADP= 0.5 g/L and enzyme at 3 g/L gave 100% conversion Goal achieved
Case Study #4-Sonogashira S. Krska/A. Northrup Medicinal Chemistry conditions
HTS Result Screened: ligands and Pd sources 32 reactions (HTS-96 well plate format) – 1.5 days- 125 mg of substrate
DOE Optimization ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
DOE Optimization ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
DOE Optimization Cu/Pd = 2
DOE Confirmation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
iChem Explorer ,[object Object],[object Object],[object Object],[object Object]
DOE Summary
Case Study # 5 Mark Weisel 10% loading Pearlman’s catalyst 25  o C/45 psi/EtOAc 88 A% Goal: to minimize formation of impurities/maximize desired product 12 A%
Case Study # 5 Mark Weisel 88 A% 12 A% DOE design: 4 Factors (19 reactions) Temp (25 and 55  o C) Pressure  (30 and 60 psi) Pd(OH) 2  loading (5 and 15 wt%) Volume EtOAc (6 and 10 ml/g)
Factors
Effect of Pd and Temp
Optimal Settings Mark Weisel ,[object Object],[object Object],[object Object],[object Object],[object Object],Selectivity improved from 88 A% to > 99 A%
DOE Benefits ,[object Object],[object Object],[object Object],[object Object],[object Object]
Take Home Message ,[object Object],[object Object],[object Object],[object Object],[object Object]
Acknowledgments ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
QUESTIONS ?

More Related Content

What's hot

QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)
QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)
QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)Satigayatri
 
Errors in Research
Errors in ResearchErrors in Research
Errors in ResearchTANUSISODIA2
 
DENOVO DRUG DESIGN AS PER PCI SYLLABUS M.PHARM
DENOVO DRUG DESIGN AS PER PCI SYLLABUS M.PHARMDENOVO DRUG DESIGN AS PER PCI SYLLABUS M.PHARM
DENOVO DRUG DESIGN AS PER PCI SYLLABUS M.PHARMShikha Popali
 
Medical Research Pharmacy
Medical Research PharmacyMedical Research Pharmacy
Medical Research PharmacyAparna Yadav
 
CoMFA CoMFA Comparative Molecular Field Analysis)
CoMFA CoMFA Comparative Molecular Field Analysis)CoMFA CoMFA Comparative Molecular Field Analysis)
CoMFA CoMFA Comparative Molecular Field Analysis)Pinky Vincent
 
Response surface method
Response surface methodResponse surface method
Response surface methodIrfan Hussain
 
Preparation of Clinical Trial Protocol of India.
Preparation of Clinical Trial Protocol of India.Preparation of Clinical Trial Protocol of India.
Preparation of Clinical Trial Protocol of India.Aakashdeep Raval
 
drug like property concepts in pharmaceutical design
drug like property concepts in pharmaceutical designdrug like property concepts in pharmaceutical design
drug like property concepts in pharmaceutical designDeepak Rohilla
 
Atmospheric Pressure Chemical Ionization
Atmospheric Pressure Chemical IonizationAtmospheric Pressure Chemical Ionization
Atmospheric Pressure Chemical IonizationVISHAL THAKUR
 
STATISTICAL METHOD OF QSAR
STATISTICAL METHOD OF QSARSTATISTICAL METHOD OF QSAR
STATISTICAL METHOD OF QSARRaniBhagat1
 
Partial Least Square model.pdf
Partial Least Square model.pdfPartial Least Square model.pdf
Partial Least Square model.pdfbhaskarpathak15
 
Fragmentation rules mass spectroscopy
Fragmentation rules mass spectroscopyFragmentation rules mass spectroscopy
Fragmentation rules mass spectroscopySanthosh Kalakar dj
 
Herg assay,Structure, Various screening methods and Advantages
Herg assay,Structure,  Various screening methods and AdvantagesHerg assay,Structure,  Various screening methods and Advantages
Herg assay,Structure, Various screening methods and AdvantagesUrvashi Shakarwal
 
Research Methodology_UNIT_I_General Research Methodology M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_I_General Research Methodology M. Pharm (IIIrd Sem.)Research Methodology_UNIT_I_General Research Methodology M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_I_General Research Methodology M. Pharm (IIIrd Sem.)Prachi Pandey
 
Regulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ichRegulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ichAnimatedWorld
 
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...RAHUL PAL
 
Free wilson analysis
Free wilson analysisFree wilson analysis
Free wilson analysisASHOK GAUTAM
 
Cross over design, Placebo and blinding techniques
Cross over design, Placebo and blinding techniques Cross over design, Placebo and blinding techniques
Cross over design, Placebo and blinding techniques Dinesh Gangoda
 
PHARMACOHORE MAPPING AND VIRTUAL SCRRENING FOR RESEARCH DEPARTMENT
PHARMACOHORE MAPPING AND VIRTUAL SCRRENING FOR RESEARCH DEPARTMENTPHARMACOHORE MAPPING AND VIRTUAL SCRRENING FOR RESEARCH DEPARTMENT
PHARMACOHORE MAPPING AND VIRTUAL SCRRENING FOR RESEARCH DEPARTMENTShikha Popali
 

What's hot (20)

QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)
QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)
QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)
 
Errors in Research
Errors in ResearchErrors in Research
Errors in Research
 
DENOVO DRUG DESIGN AS PER PCI SYLLABUS M.PHARM
DENOVO DRUG DESIGN AS PER PCI SYLLABUS M.PHARMDENOVO DRUG DESIGN AS PER PCI SYLLABUS M.PHARM
DENOVO DRUG DESIGN AS PER PCI SYLLABUS M.PHARM
 
Medical Research Pharmacy
Medical Research PharmacyMedical Research Pharmacy
Medical Research Pharmacy
 
CoMFA CoMFA Comparative Molecular Field Analysis)
CoMFA CoMFA Comparative Molecular Field Analysis)CoMFA CoMFA Comparative Molecular Field Analysis)
CoMFA CoMFA Comparative Molecular Field Analysis)
 
Response surface method
Response surface methodResponse surface method
Response surface method
 
Preparation of Clinical Trial Protocol of India.
Preparation of Clinical Trial Protocol of India.Preparation of Clinical Trial Protocol of India.
Preparation of Clinical Trial Protocol of India.
 
drug like property concepts in pharmaceutical design
drug like property concepts in pharmaceutical designdrug like property concepts in pharmaceutical design
drug like property concepts in pharmaceutical design
 
Atmospheric Pressure Chemical Ionization
Atmospheric Pressure Chemical IonizationAtmospheric Pressure Chemical Ionization
Atmospheric Pressure Chemical Ionization
 
STATISTICAL METHOD OF QSAR
STATISTICAL METHOD OF QSARSTATISTICAL METHOD OF QSAR
STATISTICAL METHOD OF QSAR
 
Partial Least Square model.pdf
Partial Least Square model.pdfPartial Least Square model.pdf
Partial Least Square model.pdf
 
Fragmentation rules mass spectroscopy
Fragmentation rules mass spectroscopyFragmentation rules mass spectroscopy
Fragmentation rules mass spectroscopy
 
Herg assay,Structure, Various screening methods and Advantages
Herg assay,Structure,  Various screening methods and AdvantagesHerg assay,Structure,  Various screening methods and Advantages
Herg assay,Structure, Various screening methods and Advantages
 
Research Methodology_UNIT_I_General Research Methodology M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_I_General Research Methodology M. Pharm (IIIrd Sem.)Research Methodology_UNIT_I_General Research Methodology M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_I_General Research Methodology M. Pharm (IIIrd Sem.)
 
Regulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ichRegulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ich
 
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
 
Chewable tablet of ginger wjpps
Chewable tablet of ginger wjppsChewable tablet of ginger wjpps
Chewable tablet of ginger wjpps
 
Free wilson analysis
Free wilson analysisFree wilson analysis
Free wilson analysis
 
Cross over design, Placebo and blinding techniques
Cross over design, Placebo and blinding techniques Cross over design, Placebo and blinding techniques
Cross over design, Placebo and blinding techniques
 
PHARMACOHORE MAPPING AND VIRTUAL SCRRENING FOR RESEARCH DEPARTMENT
PHARMACOHORE MAPPING AND VIRTUAL SCRRENING FOR RESEARCH DEPARTMENTPHARMACOHORE MAPPING AND VIRTUAL SCRRENING FOR RESEARCH DEPARTMENT
PHARMACOHORE MAPPING AND VIRTUAL SCRRENING FOR RESEARCH DEPARTMENT
 

Viewers also liked

Application of Design of Experiments (DOE) using Dr.Taguchi -Orthogonal Array...
Application of Design of Experiments (DOE) using Dr.Taguchi -Orthogonal Array...Application of Design of Experiments (DOE) using Dr.Taguchi -Orthogonal Array...
Application of Design of Experiments (DOE) using Dr.Taguchi -Orthogonal Array...Karthikeyan Kannappan
 
Exploring Best Practises in Design of Experiments: A Data Driven Approach to ...
Exploring Best Practises in Design of Experiments: A Data Driven Approach to ...Exploring Best Practises in Design of Experiments: A Data Driven Approach to ...
Exploring Best Practises in Design of Experiments: A Data Driven Approach to ...JMP software from SAS
 
Process Optimization Using Design of Experiments | An Albemarle Fine Chemical...
Process Optimization Using Design of Experiments | An Albemarle Fine Chemical...Process Optimization Using Design of Experiments | An Albemarle Fine Chemical...
Process Optimization Using Design of Experiments | An Albemarle Fine Chemical...Albemarle Fine Chemistry Services
 
Steps For A Screening DOE
Steps For A Screening DOESteps For A Screening DOE
Steps For A Screening DOEThomas Abraham
 
Re activities in egypt and environmental impact
Re activities in egypt  and environmental impactRe activities in egypt  and environmental impact
Re activities in egypt and environmental impactRCREEE
 
When a Linear Model Just Won't Do: Fitting Nonlinear Models in JMP
When a Linear Model Just Won't Do: Fitting Nonlinear Models in JMPWhen a Linear Model Just Won't Do: Fitting Nonlinear Models in JMP
When a Linear Model Just Won't Do: Fitting Nonlinear Models in JMPJMP software from SAS
 
Sustainable chemistry seminar
Sustainable chemistry seminarSustainable chemistry seminar
Sustainable chemistry seminarKatherine Haxton
 
Chemistry Presentation Show
Chemistry  Presentation  ShowChemistry  Presentation  Show
Chemistry Presentation ShowChris13Airhead
 
Short Metal-Metal Bond Distances Containing the Indium tris(3,5-dimethyl)-1 P...
Short Metal-Metal Bond Distances Containing the Indium tris(3,5-dimethyl)-1 P...Short Metal-Metal Bond Distances Containing the Indium tris(3,5-dimethyl)-1 P...
Short Metal-Metal Bond Distances Containing the Indium tris(3,5-dimethyl)-1 P...Brandon Alexander
 
FMEA, DoE & PAT : Three Inseparable Organs of Quality Risk Management (QRM) B...
FMEA, DoE & PAT : Three Inseparable Organs of Quality Risk Management (QRM) B...FMEA, DoE & PAT : Three Inseparable Organs of Quality Risk Management (QRM) B...
FMEA, DoE & PAT : Three Inseparable Organs of Quality Risk Management (QRM) B...Shivang Chaudhary
 
Quality By Design
Quality By DesignQuality By Design
Quality By Designrealmayank
 
Biomimetic Inorganic Chemistry presentation
Biomimetic Inorganic Chemistry presentationBiomimetic Inorganic Chemistry presentation
Biomimetic Inorganic Chemistry presentationJean-Marc Choufani
 
Deney tasarımı (rapor)
Deney tasarımı (rapor)Deney tasarımı (rapor)
Deney tasarımı (rapor)Habip TAYLAN
 
將將_打造將才基因_杜書伍_筆記摘要
將將_打造將才基因_杜書伍_筆記摘要將將_打造將才基因_杜書伍_筆記摘要
將將_打造將才基因_杜書伍_筆記摘要士杰 戴
 

Viewers also liked (20)

Application of Design of Experiments (DOE) using Dr.Taguchi -Orthogonal Array...
Application of Design of Experiments (DOE) using Dr.Taguchi -Orthogonal Array...Application of Design of Experiments (DOE) using Dr.Taguchi -Orthogonal Array...
Application of Design of Experiments (DOE) using Dr.Taguchi -Orthogonal Array...
 
Exploring Best Practises in Design of Experiments: A Data Driven Approach to ...
Exploring Best Practises in Design of Experiments: A Data Driven Approach to ...Exploring Best Practises in Design of Experiments: A Data Driven Approach to ...
Exploring Best Practises in Design of Experiments: A Data Driven Approach to ...
 
Process Optimization Using Design of Experiments | An Albemarle Fine Chemical...
Process Optimization Using Design of Experiments | An Albemarle Fine Chemical...Process Optimization Using Design of Experiments | An Albemarle Fine Chemical...
Process Optimization Using Design of Experiments | An Albemarle Fine Chemical...
 
Steps For A Screening DOE
Steps For A Screening DOESteps For A Screening DOE
Steps For A Screening DOE
 
A Primer in Statistical Discovery
A Primer in Statistical DiscoveryA Primer in Statistical Discovery
A Primer in Statistical Discovery
 
Quality-by-Design by chattar
Quality-by-Design by chattarQuality-by-Design by chattar
Quality-by-Design by chattar
 
Design of experiments
Design of experimentsDesign of experiments
Design of experiments
 
Quality by Design : Design of experiments
Quality by Design : Design of experimentsQuality by Design : Design of experiments
Quality by Design : Design of experiments
 
Re activities in egypt and environmental impact
Re activities in egypt  and environmental impactRe activities in egypt  and environmental impact
Re activities in egypt and environmental impact
 
Building Better Models
Building Better ModelsBuilding Better Models
Building Better Models
 
When a Linear Model Just Won't Do: Fitting Nonlinear Models in JMP
When a Linear Model Just Won't Do: Fitting Nonlinear Models in JMPWhen a Linear Model Just Won't Do: Fitting Nonlinear Models in JMP
When a Linear Model Just Won't Do: Fitting Nonlinear Models in JMP
 
Sustainable chemistry seminar
Sustainable chemistry seminarSustainable chemistry seminar
Sustainable chemistry seminar
 
Chemistry Presentation Show
Chemistry  Presentation  ShowChemistry  Presentation  Show
Chemistry Presentation Show
 
Short Metal-Metal Bond Distances Containing the Indium tris(3,5-dimethyl)-1 P...
Short Metal-Metal Bond Distances Containing the Indium tris(3,5-dimethyl)-1 P...Short Metal-Metal Bond Distances Containing the Indium tris(3,5-dimethyl)-1 P...
Short Metal-Metal Bond Distances Containing the Indium tris(3,5-dimethyl)-1 P...
 
Deney tasarımı
Deney tasarımıDeney tasarımı
Deney tasarımı
 
FMEA, DoE & PAT : Three Inseparable Organs of Quality Risk Management (QRM) B...
FMEA, DoE & PAT : Three Inseparable Organs of Quality Risk Management (QRM) B...FMEA, DoE & PAT : Three Inseparable Organs of Quality Risk Management (QRM) B...
FMEA, DoE & PAT : Three Inseparable Organs of Quality Risk Management (QRM) B...
 
Quality By Design
Quality By DesignQuality By Design
Quality By Design
 
Biomimetic Inorganic Chemistry presentation
Biomimetic Inorganic Chemistry presentationBiomimetic Inorganic Chemistry presentation
Biomimetic Inorganic Chemistry presentation
 
Deney tasarımı (rapor)
Deney tasarımı (rapor)Deney tasarımı (rapor)
Deney tasarımı (rapor)
 
將將_打造將才基因_杜書伍_筆記摘要
將將_打造將才基因_杜書伍_筆記摘要將將_打造將才基因_杜書伍_筆記摘要
將將_打造將才基因_杜書伍_筆記摘要
 

Similar to DOE Applications in Process Chemistry Presentation

design of experiments
design of experimentsdesign of experiments
design of experimentssigma-tau
 
Doe As Process Control Introduction
Doe As Process Control IntroductionDoe As Process Control Introduction
Doe As Process Control IntroductionKelly Brown
 
Upfront Thinking to Design a Better Lab Scale DoE
Upfront Thinking to Design a Better Lab Scale DoEUpfront Thinking to Design a Better Lab Scale DoE
Upfront Thinking to Design a Better Lab Scale DoEplaced1
 
Introduction to Design of Experiments by Teck Nam Ang (University of Malaya)
Introduction to Design of Experiments by Teck Nam Ang (University of Malaya)Introduction to Design of Experiments by Teck Nam Ang (University of Malaya)
Introduction to Design of Experiments by Teck Nam Ang (University of Malaya)Teck Nam Ang
 
Industrial plant optimization in reduced dimensional spaces
Industrial plant optimization in reduced dimensional spacesIndustrial plant optimization in reduced dimensional spaces
Industrial plant optimization in reduced dimensional spacesCapstone
 
Reactor Modeling Tools - STANJAN
Reactor Modeling Tools - STANJANReactor Modeling Tools - STANJAN
Reactor Modeling Tools - STANJANGerard B. Hawkins
 
Quality Management.ppt
Quality Management.pptQuality Management.ppt
Quality Management.pptddelucy
 
E00 program-level modeling and simulation experiences
E00   program-level modeling and simulation experiencesE00   program-level modeling and simulation experiences
E00 program-level modeling and simulation experiencestherealreverendbayes
 
Applied Reliability Symposium 2009 M Turner
Applied Reliability Symposium 2009 M TurnerApplied Reliability Symposium 2009 M Turner
Applied Reliability Symposium 2009 M TurnerMark Turner CRP
 
Sequential Design – The Challenge Of Multiphase Systems Pd
Sequential Design – The Challenge Of Multiphase Systems  PdSequential Design – The Challenge Of Multiphase Systems  Pd
Sequential Design – The Challenge Of Multiphase Systems PdJames Ward
 
Planning of experiment in industrial research
Planning of experiment in industrial researchPlanning of experiment in industrial research
Planning of experiment in industrial researchpbbharate
 
Advanced DOE with Minitab (presentation in Costa Rica)
Advanced DOE with Minitab (presentation in Costa Rica)Advanced DOE with Minitab (presentation in Costa Rica)
Advanced DOE with Minitab (presentation in Costa Rica)Blackberry&Cross
 
1 2 chem plantdesign-intro to plant design economics
1 2 chem plantdesign-intro to plant design  economics1 2 chem plantdesign-intro to plant design  economics
1 2 chem plantdesign-intro to plant design economicsayimsevenfold
 
How to Setup and Adjust the Dynamic Compensation of Feedforward Signals
How to Setup and Adjust the Dynamic Compensation of Feedforward SignalsHow to Setup and Adjust the Dynamic Compensation of Feedforward Signals
How to Setup and Adjust the Dynamic Compensation of Feedforward SignalsJim Cahill
 

Similar to DOE Applications in Process Chemistry Presentation (20)

design of experiments
design of experimentsdesign of experiments
design of experiments
 
Doe As Process Control Introduction
Doe As Process Control IntroductionDoe As Process Control Introduction
Doe As Process Control Introduction
 
Upfront Thinking to Design a Better Lab Scale DoE
Upfront Thinking to Design a Better Lab Scale DoEUpfront Thinking to Design a Better Lab Scale DoE
Upfront Thinking to Design a Better Lab Scale DoE
 
Tongkat Ali Extraction Process
Tongkat Ali Extraction ProcessTongkat Ali Extraction Process
Tongkat Ali Extraction Process
 
Introduction to Design of Experiments by Teck Nam Ang (University of Malaya)
Introduction to Design of Experiments by Teck Nam Ang (University of Malaya)Introduction to Design of Experiments by Teck Nam Ang (University of Malaya)
Introduction to Design of Experiments by Teck Nam Ang (University of Malaya)
 
Industrial plant optimization in reduced dimensional spaces
Industrial plant optimization in reduced dimensional spacesIndustrial plant optimization in reduced dimensional spaces
Industrial plant optimization in reduced dimensional spaces
 
Doe
DoeDoe
Doe
 
Reactor Modeling Tools - STANJAN
Reactor Modeling Tools - STANJANReactor Modeling Tools - STANJAN
Reactor Modeling Tools - STANJAN
 
Quality Management.ppt
Quality Management.pptQuality Management.ppt
Quality Management.ppt
 
Evolutionary Operation
Evolutionary OperationEvolutionary Operation
Evolutionary Operation
 
om
omom
om
 
om
omom
om
 
E00 program-level modeling and simulation experiences
E00   program-level modeling and simulation experiencesE00   program-level modeling and simulation experiences
E00 program-level modeling and simulation experiences
 
Applied Reliability Symposium 2009 M Turner
Applied Reliability Symposium 2009 M TurnerApplied Reliability Symposium 2009 M Turner
Applied Reliability Symposium 2009 M Turner
 
Sequential Design – The Challenge Of Multiphase Systems Pd
Sequential Design – The Challenge Of Multiphase Systems  PdSequential Design – The Challenge Of Multiphase Systems  Pd
Sequential Design – The Challenge Of Multiphase Systems Pd
 
Planning of experiment in industrial research
Planning of experiment in industrial researchPlanning of experiment in industrial research
Planning of experiment in industrial research
 
Aqbd seminar DOE
Aqbd seminar DOEAqbd seminar DOE
Aqbd seminar DOE
 
Advanced DOE with Minitab (presentation in Costa Rica)
Advanced DOE with Minitab (presentation in Costa Rica)Advanced DOE with Minitab (presentation in Costa Rica)
Advanced DOE with Minitab (presentation in Costa Rica)
 
1 2 chem plantdesign-intro to plant design economics
1 2 chem plantdesign-intro to plant design  economics1 2 chem plantdesign-intro to plant design  economics
1 2 chem plantdesign-intro to plant design economics
 
How to Setup and Adjust the Dynamic Compensation of Feedforward Signals
How to Setup and Adjust the Dynamic Compensation of Feedforward SignalsHow to Setup and Adjust the Dynamic Compensation of Feedforward Signals
How to Setup and Adjust the Dynamic Compensation of Feedforward Signals
 

DOE Applications in Process Chemistry Presentation

  • 1. Design of Experiments (DOE): A “New” Approach to Reaction Optimization Dr. Steven Weissman Merck & Co. Feb 4, 2008/UPR
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10. Automated Synthesis Cycle Design Experiment Analysis Informatics
  • 11. Automated Synthesis Cycle Design Experiment Analysis Informatics Design of Experiments
  • 12.
  • 13.
  • 14. Example of OFAT (11/07)
  • 16.
  • 17.
  • 18.
  • 19. DoE Introduction Core Knowledge (Engineering, Chemistry, Biology,…) Statistical Knowledge Develop Solutions DOE is NOT a replacement for process knowledge
  • 20.
  • 21.
  • 22.
  • 23.
  • 24.
  • 25. High Throughput Screening = 96 x Discreet variables- ‘The what” What is the best ligand/catalyst combination ? What is the best solvent ?
  • 26. High Throughput Screening = 96 x Can we do OPTIMIZATION this way too ??
  • 27. High Throughput Optimization ?? = 96 x If so,………………….. Which reactions do we run ? How do assess the data ?
  • 28. High Throughput Optimization ?? = 96 x Statistical Design of Experiments (DOE)
  • 30.
  • 31. DOE Design (N=27) 64 0.25 1.85 0.875 4 100 20 58 0.25 1.85 0.875 2 100 19 66 0.25 1.85 0.875 3 115 18 64 0.25 1.85 0.875 3 85 17 76 0.4 2.5 1.5 4 115 16 80 0.1 2.5 1.5 4 85 15 65 0.1 2.5 1.5 2 115 14 79 0.4 2.5 1.5 2 85 13 76 0.1 2.5 0.25 4 115 12 88 0.4 2.5 0.25 4 85 11 63 0.4 2.5 0.25 2 115 10 48 0.1 2.5 0.25 2 85 9 54 0.1 1.2 1.5 4 115 8 39 0.4 1.2 1.5 4 85 7 55 0.4 1.2 1.5 2 115 6 45 0.1 1.2 1.5 2 85 5 55 0.4 1.2 0.25 4 115 4 43 0.1 1.2 0.25 4 85 3 49 0.1 1.2 0.25 2 115 2 45 0.4 1.2 0.25 2 85 1 Yield E:Conc D:Boron/Br C:Cu B:P/Pd A:temp Rxn # Response 1 Factor 5 Factor 4 Factor 3 Factor 2 Factor 1
  • 32. DOE Creates a Design Space Design-Expert® Software Yield X1 = A: temp X2 = B: P/Pd X3 = C: Cu load Actual Factors D: Boron/Br = 2.50 E: Conc = 0.40 Cube Yield A: temp B: P/Pd C: Cu load A-: 85.00 A+: 115.00 B-: 2.00 B+: 4.00 C-: 0.25 C+: 1.50 63.7936 74.1825 86.3492 83.738 59.9047 70.2936 82.4603 79.8492
  • 33. DOE Expts: How Many ? screening optimaztion 29 9 11 9 5 27 10 7 10 4 17 5 7 5 3 35 16 3 16 5 19 8 3 8 4 11 4 3 4 3 factors Total rxns Lo Med HI rxns factors
  • 35. MK-0518 First-in-Class Oral HIV-1 Integrase Inhibitor Approved by FDA October-12-2007
  • 37. MK-0518 Challenge: to reduce manufacture cost by 20%
  • 38. MK-518: Problem step Peter Maligres Existing Conditions : 4 eq Mg(OMe) 2 / 4 eq MeI @ 0.5 M (68% isolated yield) 18 solvents, 8 bases screened 78 22
  • 39. MK-518: DOE Optimization Peter Maligres DOE Optimzation Design Factors : Mg(OMe) 2 equiv: 1.0 and 3.0 MeI equiv: 2.5 and 5.0 Conc: 0.25 and 1.0 M Temperature: 30 and 65 o C 19 reactions Responses (4 and 20 h): Assay yield Selectivity
  • 40. MK-518 Optimization Peter Maligres DOE Optimal Settings Base equiv: 1.0 and 3.0 MeI equiv: 2.5 and 5.0 Temperature: 30 and 65 o C Conc: 0.25 and 1.0 M Time: 4 and 20 h 99 1
  • 42. Effect of Temp & Conc
  • 43. Effect of Base and Conc
  • 44. MK518-In Situ Demethylation 99/1 80/20 N vs O 99% 95% Conv 20 h 4 h
  • 45.
  • 46. MK-518 Optimization Peter Maligres Yield =90% Selectivity = >99.9 % Safer, more economical reagents Incorporated best practices from DOE: HI Temp/HI Concentration/Longer reaction times
  • 47. MK-518 Summary 78 22 > 99 < 1 DOE Goal of 20% reduction in drug inventory cost was achieved Higher Yield cascades back to allow fewer RM/solvents to be used Submitted for 2008 Presidential Green Chemistry Award
  • 48.
  • 49. Case Study 2- Suzuki DOE Factors : Ligand/Pd ratio: 1.0 and 3.0 Catalyst load: 0.1 and 0.5 mole% Molarity boronic acid: 0.5 and 1.5 Temperature: 60 and 80 o C 27 Reactions in 96-well plate format, 2 days to plan/setup/execute/assay 0.65 g material (24 mg/rxn) !!
  • 50. Case Study 2- Suzuki DOE Optimal Settings : Ligand/Pd ratio: 1.0 and 3.0 Catalyst load: 0.1 and 0.5 mole% Molarity boronic acid : 0.5 and 1.5 Temperature: 60 and 80 o C ( 65 o C )
  • 51. Effect of Temp and Pd Loading Lig/ catalyst ratio fixed at 3:1; Triol M fixed at 1.5 M Overall LCAP
  • 52. Optimized Conditions Optimized Experiment: -increased LCAP by 1% -decreased DesBr impurity (50%) -decreased Pd by 75% -decreased Lig by 70% Spencer Dreher
  • 53. Case Study #3 Dave Pollard Goal: to reduce cost by increasing productivity 100 g/L
  • 54. Screening Design Dave Pollard Factors Octanol: 40 and 60 % NADP equiv: 0.1 and 0.5 % Concentration: 50 and 150 g/L Temp: 25 and 35 o C Enzyme load: 0.3 to 1.0 g/L 19 experiments
  • 55. DOE Factors Plot
  • 57. Screening Result Dave Pollard Factor Preferred Setting Octanol: 40 and 60 % No impact NADP equiv: 0.1 and 0.5 % No impact- increase more ? Concentration: 50 and 150 g/L 50 g/L- undesirable setting Temp: 25 and 35 o C minimal effect- set at 30 o C Enzyme load: 0.3 to 1.0 g/L 1.0 g/L- increase more
  • 58. Optimization Design Dave Pollard Factor NADP equiv: 0.5 and 1.5 % Concentration: 100 and 200 g/L Enzyme load: 0.5 to 3.0 g/L 19 experiments
  • 59. Optimization Design Factor Preferred setting NADP equiv: 0.5 and 1.5 % No effect Concentration: 100 and 200 g/L 200 Enzyme load: 0.5 to 3.0 g/L 3.0
  • 60. Optimization Design Factor Preferred setting NADP equiv: 0.5 and 1.5 % No effect Concentration: 100 and 200 g/L 200 Enzyme load: 0.5 to 3.0 g/L 3.0 Confirming experiment at 200 g/L NADP= 0.5 g/L and enzyme at 3 g/L gave 100% conversion Goal achieved
  • 61. Case Study #4-Sonogashira S. Krska/A. Northrup Medicinal Chemistry conditions
  • 62. HTS Result Screened: ligands and Pd sources 32 reactions (HTS-96 well plate format) – 1.5 days- 125 mg of substrate
  • 63.
  • 64.
  • 66.
  • 67.
  • 69. Case Study # 5 Mark Weisel 10% loading Pearlman’s catalyst 25 o C/45 psi/EtOAc 88 A% Goal: to minimize formation of impurities/maximize desired product 12 A%
  • 70. Case Study # 5 Mark Weisel 88 A% 12 A% DOE design: 4 Factors (19 reactions) Temp (25 and 55 o C) Pressure (30 and 60 psi) Pd(OH) 2 loading (5 and 15 wt%) Volume EtOAc (6 and 10 ml/g)
  • 72. Effect of Pd and Temp
  • 73.
  • 74.
  • 75.
  • 76.

Editor's Notes

  1. mature categories: anti-hypertensives/anti-biotics/cholesterol unmet needs: cancer/alzheimers/obesity mature therapies = anti-hypertensive, antibiotics……. protein-based drugs and vaccines have greater opportunities
  2. Develop infrastructure in those countries
  3. Fosamax-coming off patent this week. Feb 6 Insurers/benefits managers/consumers
  4. Fosamax-coming off patent this week. Feb 6
  5. Automation: not necessarily always a robot.- can be any tool that speeds up a workflow or allows a chemist to perform more value added tasks.
  6. interaction = dependance of one factor on the setting of another
  7. Statistical methods are tools used to make sense out of numbers. This slide illustrates the combination of statistical methods with your core knowledge. Statistical methods (specifically, designed experiments in today’s course) are a catalyst to science, NOT a substitute for it.
  8. lead in to next slide: How to run the rxns ????
  9. Existing experience using HTS
  10. Here is the question we are now asking ourselves at Merck…..
  11. Isentress generically known as Raltegravir. 1 st commercial HIV integrase inhibitor. Over 3 dozen people from process res
  12. Retro: oxadiazole/aza-lactone (oxo-pyrimidine)/fluoro-benzylamine
  13. 10 step process
  14. trimethyl sulfoxonium iodide
  15. Note that the low setting for Pd still gave good results !! and thus was chosen
  16. Octanol =NO EFFECT ( not included)
  17. enol ether reduction last one: oxidative cleavage
  18. enol ether reduction last one: oxidative cleavage